TABLE 2.
Prevalence of cervical HPV infection and HPV-16 IgG and IgA antibodies in control women according to sociodemographic, smoking, and alcohol use characteristics
| Variable | Prevalence ofb:
|
|||||
|---|---|---|---|---|---|---|
| HPV DNA
|
HPV-16 IgG
|
HPV-16 IgA
|
||||
| % Positive (n = 1,002a) | OR (95% CI) | % Positive (n = 908) | OR (95% CI) | % Positive (n = 904) | OR (95% CI) | |
| Age | ||||||
| <30 | 41.8 | 2.6 (1.4-4.9) | 60 | 2.9 (1.6-5.3) | 14.5 | 0.4 (0.2-9.7) |
| 30-34 | 37.9 | 2.2 (1.3-4.0) | 40.5 | 1.3 (0.74-2.3) | 15.9 | 0.5 (0.3-1.0) |
| 35-39 | 27.7 | 1.4 (0.8-2.5) | 51.6 | 2.1 (1.2-3.4) | 25.0 | 0.9 (0.5-1.5) |
| 40-44 | 25.1 | 1.2 (0.7-2.1) | 50.3 | 2.0 (1.2-3.2) | 31.6 | 1.2 (0.7-2.0) |
| 45-49 | 18.6 | 0.8 (0.5-1.5) | 41.5 | 1.4 (0.8-2.2) | 33.9 | 1.3 (0.8-2.2) |
| 50-54 | 23.5 | 1.1 (0.7-2.0) | 36.2 | 1.1 (0.7-1.8) | 36.9 | 1.5 (0.9-2.6) |
| 55-59 | 21.4 | 1.0 | 34.2 | 1.0 | 27.6 | 1.0 |
| Race | ||||||
| Mixed | 24.5 | 1.0 | 41.26 | 1.0 | 30.4 | 1.0 |
| Black | 30.2 | 1.3 (0.9-1.7) | 51.88 | 1.5 (1.1-2.1) | 23.9 | 0.7 (0.5-1.0) |
| Education (yr) | ||||||
| <8 | 23.1 | 1.0 | 42.2 | 1.0 | 32.7 | 1.0 |
| 8-10 | 27.7 | 1.1 (0.8-1.5) | 46.6 | 10 (0.8-1.4) | 25.9 | 0.8 (0.6-1.1) |
| >10 | 39.1 | 1.5 (0.9-2.5) | 47.4 | 1.0 (0.6-1.7) | 10.5 | 0.3 (0.2-0.7) |
| Alcohol use | ||||||
| Never | 29.2 | 1.0 | 43.3 | 1.0 | 21.8 | 1.0 |
| Past | 26.6 | 1.3 (0.8-1.9) | 40 | 0.9 (0.6-1.3) | 31.2 | 1.7 (1.1-2.6) |
| Present | 37.6 | 1.6 (1.2-2.2) | 47.0 | 1.1 (0.8-1.5) | 37.23 | 2.3 (1.7-3.2) |
| Cigarette smoking | ||||||
| Never | 31.9 | 1.0 | 51.6 | 1.0 | 23.8 | 1.0 |
| Past | 20.6 | 0.5 (0.3-1.0) | 41.4 | 0.7 (0.5-1.2) | 28.3 | 1.1 (0.7-1.9) |
| Present | 34.3 | 1.2 (0.9-1.6) | 38.4 | 0.6 (0.4-0.8) | 32.8 | 1.5 (1.1-2.1) |
a
There were no demographic data available for one woman; hence, there are 1,002 and not 1,003 controls, as was the case in Table 1.
b
With the exception of OR pertaining to the age variable, the OR are age adjusted.